BHP, I-Pulse and I-ROX Enter into Strategic Collaboration to Advance New Applications of I-Pulse Technology
Pulsed power could transform mining and decarbonise key steps of the mineral extraction process BHP…
Pulsed power could transform mining and decarbonise key steps of the mineral extraction process BHP…
Seattle, Washington–(Newsfile Corp. – December 12, 2022) – Lithosphere developer KaJ Labs has announced that…
TOKYO, Dec 12, 2022 – (JCN Newswire) – ROOKIE Racing Co., Ltd. (ROOKIE Racing) and…
SINGAPORE, Dec 12, 2022 – (ACN Newswire) – Society Pass Incorporated (“SoPa”) (Nasdaq: SOPA), Southeast…
Adopting a new SaaS model, Jet Analytics Cloud is delivered via Microsoft Azure to provide…
TOKYO–(BUSINESS WIRE)–#2022GSAawards–Renesas Electronics Corporation (TSE: 6723), a premier supplier of advanced semiconductor solutions, today announced…
SAN DIEGO–(BUSINESS WIRE)–$GNRC #GNRC—The Class: Robbins LLP reminds investors that a shareholder filed a class…
TOKYO, Dec 12, 2022 – (JCN Newswire) – Fujitsu today announced that it joined a…
– Data Suggest Long-term Treatment with PYRUKYND® in Adults with PK Deficiency is Associated with…
HONG KONG, Dec 12, 2022 – (ACN Newswire) – InvesTech Holdings Limited (“InvesTech Holdings”; together…
– 89% ORR in TKI-therapy naïve patients; 73% ORR in all evaluable patients with 27-week…
Transplanted hypoimmune (HIP)-modified allogeneic CD19-targeted CAR T cells control CD19+ tumor cells in fully immunocompetent…
Media Release COPENHAGEN, Denmark; December 11, 2022 Epcoritamab featured in multiple data disclosures, including four…
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR…
RVU120 Demonstrates Single-Agent Activity with a Complete Response, 4 Blast Reductions, and 4 Erythroid and/or Platelet…
Vincerx’s proprietary payload and linker technology and VIP943, a novel anti-CD123 antibody drug conjugate (ADC),…
First Preclinical Data for IGM-2644 and IGM-2537 Featured in Poster Presentations MOUNTAIN VIEW, Calif., Dec….
Lanraplenib is being evaluated in ongoing Phase 1b/2 trial in combination with gilteritinib in patients…
A single dose of KT-253 induced rapid apoptosis and sustained tumor regression in xenograft models…
HOUSTON, Dec. 11, 2022 (GLOBE NEWSWIRE) — Bellicum Pharmaceuticals, Inc. (Nasdaq: BLCM), a leader in…